nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxepin—HTR1A—Parkinson's disease	0.204	0.283	CbGaD
Doxepin—DRD2—Parkinson's disease	0.173	0.24	CbGaD
Doxepin—HTR2A—Parkinson's disease	0.134	0.186	CbGaD
Doxepin—CYP2D6—Parkinson's disease	0.122	0.17	CbGaD
Doxepin—ABCB1—Parkinson's disease	0.0874	0.121	CbGaD
Doxepin—SLC6A2—locus ceruleus—Parkinson's disease	0.00398	0.0417	CbGeAlD
Doxepin—HTR2A—enteric nervous system—Parkinson's disease	0.00362	0.0379	CbGeAlD
Doxepin—SLC6A2—sympathetic nervous system—Parkinson's disease	0.00314	0.0329	CbGeAlD
Doxepin—HTR2A—myenteric nerve plexus—Parkinson's disease	0.00274	0.0287	CbGeAlD
Doxepin—HTR2A—locus ceruleus—Parkinson's disease	0.00239	0.025	CbGeAlD
Doxepin—HTR2C—telencephalic ventricle—Parkinson's disease	0.00226	0.0237	CbGeAlD
Doxepin—SLC6A2—autonomic nervous system—Parkinson's disease	0.00211	0.0221	CbGeAlD
Doxepin—HTR2A—cerebellar cortex—Parkinson's disease	0.00195	0.0204	CbGeAlD
Doxepin—HTR1A—telencephalic ventricle—Parkinson's disease	0.0019	0.0199	CbGeAlD
Doxepin—HTR2A—sympathetic nervous system—Parkinson's disease	0.00189	0.0198	CbGeAlD
Doxepin—DRD2—telencephalic ventricle—Parkinson's disease	0.00172	0.018	CbGeAlD
Doxepin—HTR2A—pons—Parkinson's disease	0.00138	0.0144	CbGeAlD
Doxepin—HTR2A—autonomic nervous system—Parkinson's disease	0.00127	0.0133	CbGeAlD
Doxepin—SLC6A2—nerve—Parkinson's disease	0.00119	0.0125	CbGeAlD
Doxepin—HTR2A—telencephalic ventricle—Parkinson's disease	0.00113	0.0119	CbGeAlD
Doxepin—DRD2—nerve—Parkinson's disease	0.00108	0.0113	CbGeAlD
Doxepin—ADRA2A—peripheral nervous system—Parkinson's disease	0.00108	0.0113	CbGeAlD
Doxepin—HTR6—forebrain—Parkinson's disease	0.00102	0.0107	CbGeAlD
Doxepin—SLC6A4—hindbrain—Parkinson's disease	0.00101	0.0106	CbGeAlD
Doxepin—HTR2A—peripheral nervous system—Parkinson's disease	0.000916	0.0096	CbGeAlD
Doxepin—HTR1A—hindbrain—Parkinson's disease	0.000898	0.00941	CbGeAlD
Doxepin—ADRA1A—hindbrain—Parkinson's disease	0.000827	0.00867	CbGeAlD
Doxepin—DRD2—hindbrain—Parkinson's disease	0.000811	0.0085	CbGeAlD
Doxepin—ADRA1D—forebrain—Parkinson's disease	0.000797	0.00835	CbGeAlD
Doxepin—HRH2—cardiovascular system—Parkinson's disease	0.000789	0.00827	CbGeAlD
Doxepin—HTR2A—nerve—Parkinson's disease	0.000714	0.00749	CbGeAlD
Doxepin—CHRM4—head—Parkinson's disease	0.000653	0.00685	CbGeAlD
Doxepin—CHRM4—nervous system—Parkinson's disease	0.000619	0.00649	CbGeAlD
Doxepin—CHRM2—forebrain—Parkinson's disease	0.000612	0.00641	CbGeAlD
Doxepin—HTR2C—brainstem—Parkinson's disease	0.000611	0.00641	CbGeAlD
Doxepin—CHRM4—central nervous system—Parkinson's disease	0.000596	0.00625	CbGeAlD
Doxepin—HTR2C—forebrain—Parkinson's disease	0.00059	0.00618	CbGeAlD
Doxepin—HTR6—head—Parkinson's disease	0.000585	0.00613	CbGeAlD
Doxepin—SLC6A4—brainstem—Parkinson's disease	0.000579	0.00607	CbGeAlD
Doxepin—SLC6A4—forebrain—Parkinson's disease	0.000559	0.00586	CbGeAlD
Doxepin—CHRM1—forebrain—Parkinson's disease	0.000557	0.00584	CbGeAlD
Doxepin—HTR6—nervous system—Parkinson's disease	0.000554	0.00581	CbGeAlD
Doxepin—HTR2B—forebrain—Parkinson's disease	0.000554	0.00581	CbGeAlD
Doxepin—HTR2A—hindbrain—Parkinson's disease	0.000535	0.00561	CbGeAlD
Doxepin—HRH2—head—Parkinson's disease	0.000534	0.0056	CbGeAlD
Doxepin—HTR6—central nervous system—Parkinson's disease	0.000534	0.00559	CbGeAlD
Doxepin—CHRM2—cardiovascular system—Parkinson's disease	0.000518	0.00542	CbGeAlD
Doxepin—HTR1A—brainstem—Parkinson's disease	0.000514	0.00539	CbGeAlD
Doxepin—CHRM5—head—Parkinson's disease	0.000511	0.00535	CbGeAlD
Doxepin—SLC6A2—brainstem—Parkinson's disease	0.00051	0.00535	CbGeAlD
Doxepin—HRH2—nervous system—Parkinson's disease	0.000507	0.00531	CbGeAlD
Doxepin—CHRM3—forebrain—Parkinson's disease	0.000499	0.00522	CbGeAlD
Doxepin—HTR1A—forebrain—Parkinson's disease	0.000497	0.0052	CbGeAlD
Doxepin—SLC6A2—forebrain—Parkinson's disease	0.000492	0.00516	CbGeAlD
Doxepin—HRH2—central nervous system—Parkinson's disease	0.000488	0.00511	CbGeAlD
Doxepin—CYP2D6—hindbrain—Parkinson's disease	0.000487	0.00511	CbGeAlD
Doxepin—CHRM5—nervous system—Parkinson's disease	0.000484	0.00507	CbGeAlD
Doxepin—ADRA1A—brainstem—Parkinson's disease	0.000474	0.00497	CbGeAlD
Doxepin—CHRM4—brain—Parkinson's disease	0.000473	0.00496	CbGeAlD
Doxepin—CHRM1—cardiovascular system—Parkinson's disease	0.000471	0.00494	CbGeAlD
Doxepin—HTR2B—cardiovascular system—Parkinson's disease	0.000469	0.00491	CbGeAlD
Doxepin—ADRA1B—head—Parkinson's disease	0.000466	0.00489	CbGeAlD
Doxepin—CHRM5—central nervous system—Parkinson's disease	0.000466	0.00488	CbGeAlD
Doxepin—DRD2—brainstem—Parkinson's disease	0.000465	0.00487	CbGeAlD
Doxepin—ADRA1A—forebrain—Parkinson's disease	0.000458	0.0048	CbGeAlD
Doxepin—ADRA1D—head—Parkinson's disease	0.000456	0.00478	CbGeAlD
Doxepin—DRD2—forebrain—Parkinson's disease	0.000449	0.0047	CbGeAlD
Doxepin—ADRA1B—nervous system—Parkinson's disease	0.000442	0.00463	CbGeAlD
Doxepin—KCNH2—forebrain—Parkinson's disease	0.000442	0.00463	CbGeAlD
Doxepin—ADRA1D—nervous system—Parkinson's disease	0.000433	0.00453	CbGeAlD
Doxepin—HTR2C—medulla oblongata—Parkinson's disease	0.000426	0.00447	CbGeAlD
Doxepin—ADRA1B—central nervous system—Parkinson's disease	0.000426	0.00446	CbGeAlD
Doxepin—HTR6—brain—Parkinson's disease	0.000424	0.00444	CbGeAlD
Doxepin—ORM1—spinal cord—Parkinson's disease	0.000423	0.00443	CbGeAlD
Doxepin—HTR1A—cardiovascular system—Parkinson's disease	0.00042	0.0044	CbGeAlD
Doxepin—ADRA1D—central nervous system—Parkinson's disease	0.000417	0.00437	CbGeAlD
Doxepin—HTR2C—midbrain—Parkinson's disease	0.00039	0.00408	CbGeAlD
Doxepin—HRH2—brain—Parkinson's disease	0.000387	0.00406	CbGeAlD
Doxepin—ADRA1A—cardiovascular system—Parkinson's disease	0.000387	0.00406	CbGeAlD
Doxepin—HTR2C—spinal cord—Parkinson's disease	0.00038	0.00398	CbGeAlD
Doxepin—KCNH2—cardiovascular system—Parkinson's disease	0.000374	0.00392	CbGeAlD
Doxepin—CHRM5—brain—Parkinson's disease	0.00037	0.00388	CbGeAlD
Doxepin—SLC6A4—midbrain—Parkinson's disease	0.000369	0.00387	CbGeAlD
Doxepin—SLC6A4—spinal cord—Parkinson's disease	0.00036	0.00378	CbGeAlD
Doxepin—ORM1—nervous system—Parkinson's disease	0.000356	0.00373	CbGeAlD
Doxepin—SLC6A2—medulla oblongata—Parkinson's disease	0.000356	0.00373	CbGeAlD
Doxepin—HRH1—forebrain—Parkinson's disease	0.000354	0.00371	CbGeAlD
Doxepin—CHRM2—head—Parkinson's disease	0.00035	0.00367	CbGeAlD
Doxepin—ADRA2A—forebrain—Parkinson's disease	0.000348	0.00365	CbGeAlD
Doxepin—ORM1—central nervous system—Parkinson's disease	0.000343	0.00359	CbGeAlD
Doxepin—ADRA1B—brain—Parkinson's disease	0.000338	0.00354	CbGeAlD
Doxepin—HTR2C—head—Parkinson's disease	0.000338	0.00354	CbGeAlD
Doxepin—HTR2A—embryo—Parkinson's disease	0.000335	0.00351	CbGeAlD
Doxepin—CHRM2—nervous system—Parkinson's disease	0.000332	0.00348	CbGeAlD
Doxepin—ADRA1D—brain—Parkinson's disease	0.000331	0.00347	CbGeAlD
Doxepin—HTR1A—midbrain—Parkinson's disease	0.000328	0.00344	CbGeAlD
Doxepin—HTR2C—nervous system—Parkinson's disease	0.00032	0.00336	CbGeAlD
Doxepin—SLC6A4—head—Parkinson's disease	0.00032	0.00336	CbGeAlD
Doxepin—HTR1A—spinal cord—Parkinson's disease	0.00032	0.00335	CbGeAlD
Doxepin—CHRM2—central nervous system—Parkinson's disease	0.00032	0.00335	CbGeAlD
Doxepin—KCNH2—medulla oblongata—Parkinson's disease	0.000319	0.00335	CbGeAlD
Doxepin—CHRM1—head—Parkinson's disease	0.000319	0.00334	CbGeAlD
Doxepin—HTR2B—head—Parkinson's disease	0.000317	0.00333	CbGeAlD
Doxepin—ADRA2C—medulla oblongata—Parkinson's disease	0.000315	0.0033	CbGeAlD
Doxepin—HTR2C—central nervous system—Parkinson's disease	0.000308	0.00323	CbGeAlD
Doxepin—HTR2A—brainstem—Parkinson's disease	0.000307	0.00321	CbGeAlD
Doxepin—CYP2C9—cardiovascular system—Parkinson's disease	0.000304	0.00318	CbGeAlD
Doxepin—SLC6A4—nervous system—Parkinson's disease	0.000304	0.00318	CbGeAlD
Doxepin—CHRM1—nervous system—Parkinson's disease	0.000302	0.00317	CbGeAlD
Doxepin—HTR2B—nervous system—Parkinson's disease	0.000301	0.00315	CbGeAlD
Doxepin—DRD2—midbrain—Parkinson's disease	0.000296	0.0031	CbGeAlD
Doxepin—HTR2A—forebrain—Parkinson's disease	0.000296	0.0031	CbGeAlD
Doxepin—SLC6A4—central nervous system—Parkinson's disease	0.000292	0.00306	CbGeAlD
Doxepin—KCNH2—midbrain—Parkinson's disease	0.000292	0.00306	CbGeAlD
Doxepin—CHRM1—central nervous system—Parkinson's disease	0.000291	0.00305	CbGeAlD
Doxepin—HTR2B—central nervous system—Parkinson's disease	0.00029	0.00304	CbGeAlD
Doxepin—ADRA2C—midbrain—Parkinson's disease	0.000288	0.00302	CbGeAlD
Doxepin—CHRM3—head—Parkinson's disease	0.000285	0.00299	CbGeAlD
Doxepin—KCNH2—spinal cord—Parkinson's disease	0.000285	0.00298	CbGeAlD
Doxepin—HTR1A—head—Parkinson's disease	0.000284	0.00298	CbGeAlD
Doxepin—SLC6A2—head—Parkinson's disease	0.000282	0.00295	CbGeAlD
Doxepin—ADRA2C—spinal cord—Parkinson's disease	0.000281	0.00294	CbGeAlD
Doxepin—CYP2D6—brainstem—Parkinson's disease	0.000279	0.00293	CbGeAlD
Doxepin—CHRM3—nervous system—Parkinson's disease	0.000271	0.00284	CbGeAlD
Doxepin—CYP2D6—forebrain—Parkinson's disease	0.00027	0.00283	CbGeAlD
Doxepin—HTR1A—nervous system—Parkinson's disease	0.00027	0.00282	CbGeAlD
Doxepin—SLC6A2—nervous system—Parkinson's disease	0.000267	0.0028	CbGeAlD
Doxepin—ADRA1A—head—Parkinson's disease	0.000262	0.00275	CbGeAlD
Doxepin—CHRM3—central nervous system—Parkinson's disease	0.000261	0.00273	CbGeAlD
Doxepin—HTR1A—central nervous system—Parkinson's disease	0.00026	0.00272	CbGeAlD
Doxepin—SLC6A2—central nervous system—Parkinson's disease	0.000257	0.0027	CbGeAlD
Doxepin—DRD2—head—Parkinson's disease	0.000257	0.00269	CbGeAlD
Doxepin—CHRM2—brain—Parkinson's disease	0.000254	0.00266	CbGeAlD
Doxepin—HTR1A—cerebellum—Parkinson's disease	0.000254	0.00266	CbGeAlD
Doxepin—KCNH2—head—Parkinson's disease	0.000253	0.00265	CbGeAlD
Doxepin—ADRA2A—medulla oblongata—Parkinson's disease	0.000251	0.00264	CbGeAlD
Doxepin—HTR2A—cardiovascular system—Parkinson's disease	0.00025	0.00262	CbGeAlD
Doxepin—ADRA2C—head—Parkinson's disease	0.00025	0.00262	CbGeAlD
Doxepin—ADRA1A—nervous system—Parkinson's disease	0.000248	0.0026	CbGeAlD
Doxepin—HTR2C—brain—Parkinson's disease	0.000245	0.00257	CbGeAlD
Doxepin—DRD2—nervous system—Parkinson's disease	0.000244	0.00255	CbGeAlD
Doxepin—Clomipramine—GSTP1—Parkinson's disease	0.000241	0.036	CrCbGaD
Doxepin—KCNH2—nervous system—Parkinson's disease	0.00024	0.00251	CbGeAlD
Doxepin—ADRA1A—central nervous system—Parkinson's disease	0.000239	0.00251	CbGeAlD
Doxepin—ADRA2C—nervous system—Parkinson's disease	0.000237	0.00248	CbGeAlD
Doxepin—DRD2—central nervous system—Parkinson's disease	0.000234	0.00246	CbGeAlD
Doxepin—ADRA1A—cerebellum—Parkinson's disease	0.000234	0.00245	CbGeAlD
Doxepin—SLC6A4—brain—Parkinson's disease	0.000232	0.00243	CbGeAlD
Doxepin—CHRM1—brain—Parkinson's disease	0.000231	0.00242	CbGeAlD
Doxepin—KCNH2—central nervous system—Parkinson's disease	0.000231	0.00242	CbGeAlD
Doxepin—Thiothixene—DRD1—Parkinson's disease	0.000231	0.0344	CrCbGaD
Doxepin—HTR2B—brain—Parkinson's disease	0.00023	0.00241	CbGeAlD
Doxepin—ADRA2A—midbrain—Parkinson's disease	0.00023	0.00241	CbGeAlD
Doxepin—DRD2—cerebellum—Parkinson's disease	0.000229	0.0024	CbGeAlD
Doxepin—ADRA2C—central nervous system—Parkinson's disease	0.000228	0.00239	CbGeAlD
Doxepin—KCNH2—cerebellum—Parkinson's disease	0.000226	0.00237	CbGeAlD
Doxepin—ADRA2A—spinal cord—Parkinson's disease	0.000224	0.00235	CbGeAlD
Doxepin—ADRA2C—cerebellum—Parkinson's disease	0.000223	0.00234	CbGeAlD
Doxepin—ABCB1—embryo—Parkinson's disease	0.000219	0.0023	CbGeAlD
Doxepin—HTR2A—medulla oblongata—Parkinson's disease	0.000214	0.00224	CbGeAlD
Doxepin—Tripelennamine—CYP2D6—Parkinson's disease	0.000208	0.031	CrCbGaD
Doxepin—CHRM3—brain—Parkinson's disease	0.000207	0.00217	CbGeAlD
Doxepin—HTR1A—brain—Parkinson's disease	0.000206	0.00216	CbGeAlD
Doxepin—SLC6A2—brain—Parkinson's disease	0.000204	0.00214	CbGeAlD
Doxepin—HRH1—head—Parkinson's disease	0.000203	0.00213	CbGeAlD
Doxepin—ADRA2A—head—Parkinson's disease	0.000199	0.00209	CbGeAlD
Doxepin—HTR2A—midbrain—Parkinson's disease	0.000195	0.00205	CbGeAlD
Doxepin—ABCB1—forebrain—Parkinson's disease	0.000194	0.00203	CbGeAlD
Doxepin—HRH1—nervous system—Parkinson's disease	0.000192	0.00202	CbGeAlD
Doxepin—Thiothixene—HTR1A—Parkinson's disease	0.000192	0.0286	CrCbGaD
Doxepin—HTR2A—spinal cord—Parkinson's disease	0.000191	0.002	CbGeAlD
Doxepin—ADRA1A—brain—Parkinson's disease	0.00019	0.00199	CbGeAlD
Doxepin—Cyclobenzaprine—HTR2A—Parkinson's disease	0.000189	0.0282	CrCbGaD
Doxepin—ADRA2A—nervous system—Parkinson's disease	0.000189	0.00198	CbGeAlD
Doxepin—DRD2—brain—Parkinson's disease	0.000186	0.00195	CbGeAlD
Doxepin—HRH1—central nervous system—Parkinson's disease	0.000185	0.00194	CbGeAlD
Doxepin—Chlorprothixene—DRD3—Parkinson's disease	0.000185	0.0276	CrCbGaD
Doxepin—KCNH2—brain—Parkinson's disease	0.000183	0.00192	CbGeAlD
Doxepin—ADRA2A—central nervous system—Parkinson's disease	0.000182	0.00191	CbGeAlD
Doxepin—Chlorprothixene—DRD1—Parkinson's disease	0.000182	0.0271	CrCbGaD
Doxepin—ADRA2C—brain—Parkinson's disease	0.000181	0.0019	CbGeAlD
Doxepin—ADRA2A—cerebellum—Parkinson's disease	0.000178	0.00186	CbGeAlD
Doxepin—Cyclobenzaprine—CYP2D6—Parkinson's disease	0.000173	0.0258	CrCbGaD
Doxepin—HTR2A—head—Parkinson's disease	0.000169	0.00178	CbGeAlD
Doxepin—ABCB1—cardiovascular system—Parkinson's disease	0.000164	0.00172	CbGeAlD
Doxepin—Thiothixene—DRD2—Parkinson's disease	0.000163	0.0242	CrCbGaD
Doxepin—HTR2A—nervous system—Parkinson's disease	0.000161	0.00168	CbGeAlD
Doxepin—Trimipramine—SLC6A3—Parkinson's disease	0.000159	0.0237	CrCbGaD
Doxepin—HTR2A—central nervous system—Parkinson's disease	0.000155	0.00162	CbGeAlD
Doxepin—CYP2D6—head—Parkinson's disease	0.000154	0.00162	CbGeAlD
Doxepin—HTR2A—cerebellum—Parkinson's disease	0.000151	0.00158	CbGeAlD
Doxepin—CYP3A4—nervous system—Parkinson's disease	0.000149	0.00156	CbGeAlD
Doxepin—Nortriptyline—HTR1A—Parkinson's disease	0.000148	0.0221	CrCbGaD
Doxepin—HRH1—brain—Parkinson's disease	0.000147	0.00154	CbGeAlD
Doxepin—CYP2D6—nervous system—Parkinson's disease	0.000146	0.00153	CbGeAlD
Doxepin—ADRA2A—brain—Parkinson's disease	0.000144	0.00151	CbGeAlD
Doxepin—CYP3A4—central nervous system—Parkinson's disease	0.000143	0.0015	CbGeAlD
Doxepin—Promazine—DRD1—Parkinson's disease	0.000142	0.0212	CrCbGaD
Doxepin—CYP2D6—central nervous system—Parkinson's disease	0.000141	0.00148	CbGeAlD
Doxepin—ABCB1—medulla oblongata—Parkinson's disease	0.00014	0.00147	CbGeAlD
Doxepin—Trimipramine—HTR1A—Parkinson's disease	0.000139	0.0208	CrCbGaD
Doxepin—Desipramine—SLC6A3—Parkinson's disease	0.000139	0.0207	CrCbGaD
Doxepin—CYP2D6—cerebellum—Parkinson's disease	0.000138	0.00144	CbGeAlD
Doxepin—Imipramine—HTR7—Parkinson's disease	0.000135	0.0201	CrCbGaD
Doxepin—Amitriptyline—HTR7—Parkinson's disease	0.000134	0.02	CrCbGaD
Doxepin—Chlorprothixene—DRD2—Parkinson's disease	0.000128	0.0191	CrCbGaD
Doxepin—ABCB1—midbrain—Parkinson's disease	0.000128	0.00134	CbGeAlD
Doxepin—Amitriptyline—DRD3—Parkinson's disease	0.000126	0.0188	CrCbGaD
Doxepin—Thiothixene—HTR2A—Parkinson's disease	0.000126	0.0187	CrCbGaD
Doxepin—Nortriptyline—DRD2—Parkinson's disease	0.000126	0.0187	CrCbGaD
Doxepin—ABCB1—spinal cord—Parkinson's disease	0.000125	0.00131	CbGeAlD
Doxepin—HTR2A—brain—Parkinson's disease	0.000123	0.00129	CbGeAlD
Doxepin—Desipramine—HTR1A—Parkinson's disease	0.000122	0.0182	CrCbGaD
Doxepin—Nortriptyline—CYP2E1—Parkinson's disease	0.000121	0.018	CrCbGaD
Doxepin—Trimipramine—DRD2—Parkinson's disease	0.000118	0.0176	CrCbGaD
Doxepin—Imipramine—SLC6A3—Parkinson's disease	0.000118	0.0176	CrCbGaD
Doxepin—Thiothixene—CYP2D6—Parkinson's disease	0.000115	0.0171	CrCbGaD
Doxepin—Promethazine—DRD2—Parkinson's disease	0.000114	0.017	CrCbGaD
Doxepin—CYP2D6—brain—Parkinson's disease	0.000112	0.00117	CbGeAlD
Doxepin—ABCB1—head—Parkinson's disease	0.000111	0.00116	CbGeAlD
Doxepin—Orphenadrine—CYP2E1—Parkinson's disease	0.000106	0.0158	CrCbGaD
Doxepin—ABCB1—nervous system—Parkinson's disease	0.000105	0.0011	CbGeAlD
Doxepin—Desipramine—DRD2—Parkinson's disease	0.000104	0.0154	CrCbGaD
Doxepin—Imipramine—HTR1A—Parkinson's disease	0.000103	0.0154	CrCbGaD
Doxepin—Amitriptyline—HTR1A—Parkinson's disease	0.000103	0.0153	CrCbGaD
Doxepin—ABCB1—central nervous system—Parkinson's disease	0.000101	0.00106	CbGeAlD
Doxepin—Promazine—DRD2—Parkinson's disease	0.0001	0.0149	CrCbGaD
Doxepin—Desipramine—CYP2E1—Parkinson's disease	9.97e-05	0.0148	CrCbGaD
Doxepin—Clomipramine—HTR2A—Parkinson's disease	9.94e-05	0.0148	CrCbGaD
Doxepin—ABCB1—cerebellum—Parkinson's disease	9.91e-05	0.00104	CbGeAlD
Doxepin—Chlorprothixene—HTR2A—Parkinson's disease	9.9e-05	0.0147	CrCbGaD
Doxepin—Nortriptyline—HTR2A—Parkinson's disease	9.72e-05	0.0145	CrCbGaD
Doxepin—Trimipramine—HTR2A—Parkinson's disease	9.15e-05	0.0136	CrCbGaD
Doxepin—Clomipramine—CYP2D6—Parkinson's disease	9.09e-05	0.0135	CrCbGaD
Doxepin—Nortriptyline—CYP2D6—Parkinson's disease	8.89e-05	0.0132	CrCbGaD
Doxepin—Promethazine—HTR2A—Parkinson's disease	8.81e-05	0.0131	CrCbGaD
Doxepin—Imipramine—DRD2—Parkinson's disease	8.78e-05	0.0131	CrCbGaD
Doxepin—Amitriptyline—DRD2—Parkinson's disease	8.73e-05	0.013	CrCbGaD
Doxepin—Imipramine—CYP2E1—Parkinson's disease	8.45e-05	0.0126	CrCbGaD
Doxepin—Amitriptyline—CYP2E1—Parkinson's disease	8.4e-05	0.0125	CrCbGaD
Doxepin—Trimipramine—CYP2D6—Parkinson's disease	8.37e-05	0.0125	CrCbGaD
Doxepin—Diphenhydramine—CYP2D6—Parkinson's disease	8.22e-05	0.0122	CrCbGaD
Doxepin—Promethazine—CYP2D6—Parkinson's disease	8.06e-05	0.012	CrCbGaD
Doxepin—ABCB1—brain—Parkinson's disease	8.05e-05	0.000843	CbGeAlD
Doxepin—Desipramine—HTR2A—Parkinson's disease	8e-05	0.0119	CrCbGaD
Doxepin—Promazine—HTR2A—Parkinson's disease	7.75e-05	0.0115	CrCbGaD
Doxepin—Desipramine—CYP2D6—Parkinson's disease	7.32e-05	0.0109	CrCbGaD
Doxepin—Imipramine—HTR2A—Parkinson's disease	6.79e-05	0.0101	CrCbGaD
Doxepin—Amitriptyline—HTR2A—Parkinson's disease	6.74e-05	0.01	CrCbGaD
Doxepin—Clomipramine—ABCB1—Parkinson's disease	6.49e-05	0.00967	CrCbGaD
Doxepin—Chlorprothixene—ABCB1—Parkinson's disease	6.46e-05	0.00963	CrCbGaD
Doxepin—Imipramine—CYP2D6—Parkinson's disease	6.2e-05	0.00924	CrCbGaD
Doxepin—Amitriptyline—CYP2D6—Parkinson's disease	6.17e-05	0.00918	CrCbGaD
Doxepin—Trimipramine—ABCB1—Parkinson's disease	5.97e-05	0.0089	CrCbGaD
Doxepin—Promethazine—ABCB1—Parkinson's disease	5.75e-05	0.00856	CrCbGaD
Doxepin—Desipramine—ABCB1—Parkinson's disease	5.22e-05	0.00778	CrCbGaD
Doxepin—Imipramine—ABCB1—Parkinson's disease	4.43e-05	0.0066	CrCbGaD
Doxepin—Amitriptyline—ABCB1—Parkinson's disease	4.4e-05	0.00656	CrCbGaD
Doxepin—HTR2A—Signaling Pathways—IGF2—Parkinson's disease	5.72e-06	3.23e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—IGF2—Parkinson's disease	5.7e-06	3.23e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—IGF2—Parkinson's disease	5.68e-06	3.22e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—IGF2—Parkinson's disease	5.67e-06	3.21e-05	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—MTHFR—Parkinson's disease	5.66e-06	3.2e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—GPX1—Parkinson's disease	5.62e-06	3.18e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—NGF—Parkinson's disease	5.62e-06	3.18e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—IGF1R—Parkinson's disease	5.62e-06	3.18e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—IGF2—Parkinson's disease	5.61e-06	3.17e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—INS—Parkinson's disease	5.6e-06	3.17e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—IGF2—Parkinson's disease	5.6e-06	3.17e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—EDN1—Parkinson's disease	5.55e-06	3.14e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—NGF—Parkinson's disease	5.53e-06	3.13e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—HTR2A—Parkinson's disease	5.53e-06	3.13e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—IGF1R—Parkinson's disease	5.53e-06	3.13e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—IGF1R—Parkinson's disease	5.51e-06	3.12e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—HTR2A—Parkinson's disease	5.5e-06	3.11e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—IGF1R—Parkinson's disease	5.5e-06	3.11e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	5.49e-06	3.11e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—IGF1R—Parkinson's disease	5.48e-06	3.1e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	5.47e-06	3.1e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—EDN1—Parkinson's disease	5.46e-06	3.09e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GSTA4—Parkinson's disease	5.45e-06	3.08e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—EDN1—Parkinson's disease	5.45e-06	3.08e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—EDN1—Parkinson's disease	5.43e-06	3.07e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—NQO1—Parkinson's disease	5.43e-06	3.07e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—IGF1R—Parkinson's disease	5.43e-06	3.07e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—CTGF—Parkinson's disease	5.42e-06	3.07e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—INS—Parkinson's disease	5.41e-06	3.06e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—EDN1—Parkinson's disease	5.41e-06	3.06e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—IGF1R—Parkinson's disease	5.41e-06	3.06e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—CTGF—Parkinson's disease	5.37e-06	3.04e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—EDN1—Parkinson's disease	5.36e-06	3.03e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—INS—Parkinson's disease	5.36e-06	3.03e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—CYP2E1—Parkinson's disease	5.36e-06	3.03e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—HTR2A—Parkinson's disease	5.35e-06	3.03e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—TH—Parkinson's disease	5.35e-06	3.03e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—EDN1—Parkinson's disease	5.35e-06	3.02e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—APOE—Parkinson's disease	5.32e-06	3.01e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—NQO1—Parkinson's disease	5.3e-06	3e-05	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—MAPK8—Parkinson's disease	5.29e-06	2.99e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—HTR2A—Parkinson's disease	5.27e-06	2.98e-05	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—APOE—Parkinson's disease	5.27e-06	2.98e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—TH—Parkinson's disease	5.22e-06	2.95e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IGF2—Parkinson's disease	5.2e-06	2.94e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—MTHFR—Parkinson's disease	5.19e-06	2.94e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—APOE—Parkinson's disease	5.14e-06	2.91e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—CYCS—Parkinson's disease	5.14e-06	2.91e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—APOE—Parkinson's disease	5.11e-06	2.89e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—NGF—Parkinson's disease	5.1e-06	2.88e-05	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—INS—Parkinson's disease	5.08e-06	2.87e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	5.05e-06	2.86e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—INS—Parkinson's disease	5.04e-06	2.85e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IGF1R—Parkinson's disease	5.03e-06	2.84e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—NGF—Parkinson's disease	5.02e-06	2.84e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—CYCS—Parkinson's disease	5.01e-06	2.84e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—NGF—Parkinson's disease	5.01e-06	2.83e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	5.01e-06	2.83e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—NQO1—Parkinson's disease	4.99e-06	2.82e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—NGF—Parkinson's disease	4.99e-06	2.82e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—NGF—Parkinson's disease	4.97e-06	2.81e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—APOE—Parkinson's disease	4.97e-06	2.81e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—EDN1—Parkinson's disease	4.97e-06	2.81e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—NQO1—Parkinson's disease	4.95e-06	2.8e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—NGF—Parkinson's disease	4.93e-06	2.79e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—TH—Parkinson's disease	4.92e-06	2.78e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—NGF—Parkinson's disease	4.91e-06	2.78e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	4.91e-06	2.78e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—APOE—Parkinson's disease	4.9e-06	2.77e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—TH—Parkinson's disease	4.88e-06	2.76e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—MAOB—Parkinson's disease	4.86e-06	2.75e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—HTR2A—Parkinson's disease	4.85e-06	2.75e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—APOE—Parkinson's disease	4.83e-06	2.73e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—HTR2A—Parkinson's disease	4.77e-06	2.7e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—HTR2A—Parkinson's disease	4.75e-06	2.69e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—HTR2A—Parkinson's disease	4.74e-06	2.68e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—CYCS—Parkinson's disease	4.72e-06	2.67e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—HTR2A—Parkinson's disease	4.69e-06	2.65e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—CYCS—Parkinson's disease	4.68e-06	2.65e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—HTR2A—Parkinson's disease	4.68e-06	2.65e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	4.68e-06	2.65e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—CTGF—Parkinson's disease	4.59e-06	2.6e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—NGF—Parkinson's disease	4.56e-06	2.58e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—INS—Parkinson's disease	4.55e-06	2.57e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—COMT—Parkinson's disease	4.55e-06	2.57e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—GSTP1—Parkinson's disease	4.53e-06	2.56e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—MAOA—Parkinson's disease	4.52e-06	2.55e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—APOE—Parkinson's disease	4.51e-06	2.55e-05	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—INS—Parkinson's disease	4.5e-06	2.54e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—HMOX1—Parkinson's disease	4.46e-06	2.53e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—APOE—Parkinson's disease	4.44e-06	2.51e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—COMT—Parkinson's disease	4.44e-06	2.51e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—APOE—Parkinson's disease	4.43e-06	2.51e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—GSTP1—Parkinson's disease	4.42e-06	2.5e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—APOE—Parkinson's disease	4.42e-06	2.5e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—CASP3—Parkinson's disease	4.42e-06	2.5e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—MAOA—Parkinson's disease	4.41e-06	2.49e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—APOE—Parkinson's disease	4.4e-06	2.49e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—INS—Parkinson's disease	4.39e-06	2.48e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling by GPCR—IL6—Parkinson's disease	4.39e-06	2.48e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—INS—Parkinson's disease	4.37e-06	2.47e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—APOE—Parkinson's disease	4.36e-06	2.47e-05	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—IL6—Parkinson's disease	4.36e-06	2.47e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—HMOX1—Parkinson's disease	4.36e-06	2.47e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—APOE—Parkinson's disease	4.35e-06	2.46e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—HTR2A—Parkinson's disease	4.35e-06	2.46e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—ABCB1—Parkinson's disease	4.29e-06	2.42e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	4.28e-06	2.42e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—INS—Parkinson's disease	4.25e-06	2.4e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—NQO1—Parkinson's disease	4.23e-06	2.39e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—COMT—Parkinson's disease	4.18e-06	2.37e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—INS—Parkinson's disease	4.18e-06	2.37e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—TH—Parkinson's disease	4.17e-06	2.36e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—CASP3—Parkinson's disease	4.17e-06	2.36e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—GSTP1—Parkinson's disease	4.16e-06	2.36e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—GSTM1—Parkinson's disease	4.16e-06	2.35e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—MAOA—Parkinson's disease	4.15e-06	2.35e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—COMT—Parkinson's disease	4.15e-06	2.35e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling by GPCR—IL6—Parkinson's disease	4.14e-06	2.34e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—GSTP1—Parkinson's disease	4.13e-06	2.34e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—INS—Parkinson's disease	4.13e-06	2.33e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—MAOA—Parkinson's disease	4.12e-06	2.33e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—HMOX1—Parkinson's disease	4.11e-06	2.32e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—HMOX1—Parkinson's disease	4.07e-06	2.3e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—GSTM1—Parkinson's disease	4.06e-06	2.3e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—MAPK8—Parkinson's disease	4.06e-06	2.3e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—APOE—Parkinson's disease	4.04e-06	2.29e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—CASP3—Parkinson's disease	4.03e-06	2.28e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling by GPCR—IL6—Parkinson's disease	4.01e-06	2.27e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—CYCS—Parkinson's disease	4e-06	2.26e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—CASP3—Parkinson's disease	3.99e-06	2.26e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—GPX1—Parkinson's disease	3.98e-06	2.25e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling by GPCR—IL6—Parkinson's disease	3.96e-06	2.24e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—ABCB1—Parkinson's disease	3.94e-06	2.23e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—ABCB1—Parkinson's disease	3.91e-06	2.21e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—GPX1—Parkinson's disease	3.89e-06	2.2e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—INS—Parkinson's disease	3.86e-06	2.18e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—MAPK8—Parkinson's disease	3.83e-06	2.17e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—GSTM1—Parkinson's disease	3.83e-06	2.16e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—INS—Parkinson's disease	3.79e-06	2.15e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—GSTM1—Parkinson's disease	3.79e-06	2.15e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—INS—Parkinson's disease	3.79e-06	2.14e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—INS—Parkinson's disease	3.77e-06	2.13e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—INS—Parkinson's disease	3.76e-06	2.13e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—CASP3—Parkinson's disease	3.75e-06	2.12e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling by GPCR—IL6—Parkinson's disease	3.73e-06	2.11e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—INS—Parkinson's disease	3.72e-06	2.11e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—INS—Parkinson's disease	3.71e-06	2.1e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—MAPK8—Parkinson's disease	3.71e-06	2.1e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—MTHFR—Parkinson's disease	3.68e-06	2.08e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—MAPK8—Parkinson's disease	3.67e-06	2.07e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—GPX1—Parkinson's disease	3.66e-06	2.07e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—GPX1—Parkinson's disease	3.63e-06	2.05e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	3.61e-06	2.04e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—MTHFR—Parkinson's disease	3.59e-06	2.03e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—COMT—Parkinson's disease	3.54e-06	2e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CTGF—Parkinson's disease	3.54e-06	2e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—GSTP1—Parkinson's disease	3.53e-06	2e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—MAOA—Parkinson's disease	3.52e-06	1.99e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—HMOX1—Parkinson's disease	3.48e-06	1.97e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—INS—Parkinson's disease	3.45e-06	1.95e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—MAPK8—Parkinson's disease	3.45e-06	1.95e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—APOE—Parkinson's disease	3.42e-06	1.94e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—CASP3—Parkinson's disease	3.39e-06	1.92e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—MTHFR—Parkinson's disease	3.38e-06	1.91e-05	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—IL6—Parkinson's disease	3.38e-06	1.91e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—IL6—Parkinson's disease	3.36e-06	1.9e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—MTHFR—Parkinson's disease	3.35e-06	1.9e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—APOE—Parkinson's disease	3.34e-06	1.89e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—ABCB1—Parkinson's disease	3.34e-06	1.89e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	3.3e-06	1.87e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—CASP3—Parkinson's disease	3.27e-06	1.85e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—NQO1—Parkinson's disease	3.26e-06	1.85e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—CASP3—Parkinson's disease	3.25e-06	1.84e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—IL6—Parkinson's disease	3.25e-06	1.84e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—GSTM1—Parkinson's disease	3.24e-06	1.83e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—IL6—Parkinson's disease	3.23e-06	1.83e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—TH—Parkinson's disease	3.22e-06	1.82e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—CASP3—Parkinson's disease	3.16e-06	1.79e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—APOE—Parkinson's disease	3.15e-06	1.78e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—IL6—Parkinson's disease	3.14e-06	1.78e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—APOE—Parkinson's disease	3.12e-06	1.77e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CASP3—Parkinson's disease	3.11e-06	1.76e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—MAPK8—Parkinson's disease	3.11e-06	1.76e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—GPX1—Parkinson's disease	3.1e-06	1.76e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—IL6—Parkinson's disease	3.09e-06	1.75e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CYCS—Parkinson's disease	3.09e-06	1.75e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—MAPK8—Parkinson's disease	3e-06	1.7e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—MAPK8—Parkinson's disease	2.99e-06	1.69e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—INS—Parkinson's disease	2.92e-06	1.65e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—MAPK8—Parkinson's disease	2.91e-06	1.64e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CASP3—Parkinson's disease	2.87e-06	1.62e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—MTHFR—Parkinson's disease	2.86e-06	1.62e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—MAPK8—Parkinson's disease	2.86e-06	1.62e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—INS—Parkinson's disease	2.85e-06	1.61e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—IL6—Parkinson's disease	2.85e-06	1.61e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CASP3—Parkinson's disease	2.82e-06	1.6e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CASP3—Parkinson's disease	2.82e-06	1.59e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CASP3—Parkinson's disease	2.81e-06	1.59e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—IL6—Parkinson's disease	2.81e-06	1.59e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CASP3—Parkinson's disease	2.8e-06	1.58e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—IL6—Parkinson's disease	2.8e-06	1.58e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—IL6—Parkinson's disease	2.79e-06	1.58e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—IL6—Parkinson's disease	2.78e-06	1.57e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CASP3—Parkinson's disease	2.77e-06	1.57e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CASP3—Parkinson's disease	2.77e-06	1.56e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—IL6—Parkinson's disease	2.76e-06	1.56e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—IL6—Parkinson's disease	2.75e-06	1.55e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—COMT—Parkinson's disease	2.74e-06	1.55e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GSTP1—Parkinson's disease	2.72e-06	1.54e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—MAOA—Parkinson's disease	2.72e-06	1.54e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—INS—Parkinson's disease	2.69e-06	1.52e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—HMOX1—Parkinson's disease	2.68e-06	1.52e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—APOE—Parkinson's disease	2.67e-06	1.51e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—INS—Parkinson's disease	2.67e-06	1.51e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MAPK8—Parkinson's disease	2.64e-06	1.49e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MAPK8—Parkinson's disease	2.6e-06	1.47e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—IL6—Parkinson's disease	2.59e-06	1.47e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MAPK8—Parkinson's disease	2.59e-06	1.47e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MAPK8—Parkinson's disease	2.58e-06	1.46e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—ABCB1—Parkinson's disease	2.58e-06	1.46e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MAPK8—Parkinson's disease	2.57e-06	1.46e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CASP3—Parkinson's disease	2.57e-06	1.45e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—IL6—Parkinson's disease	2.55e-06	1.44e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MAPK8—Parkinson's disease	2.55e-06	1.44e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MAPK8—Parkinson's disease	2.54e-06	1.44e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GSTM1—Parkinson's disease	2.5e-06	1.42e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—IL6—Parkinson's disease	2.45e-06	1.38e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GPX1—Parkinson's disease	2.4e-06	1.36e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—IL6—Parkinson's disease	2.37e-06	1.34e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MAPK8—Parkinson's disease	2.36e-06	1.34e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—IL6—Parkinson's disease	2.34e-06	1.32e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—INS—Parkinson's disease	2.28e-06	1.29e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—MTHFR—Parkinson's disease	2.21e-06	1.25e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—IL6—Parkinson's disease	2.2e-06	1.25e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—APOE—Parkinson's disease	2.06e-06	1.16e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—IL6—Parkinson's disease	1.99e-06	1.12e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—IL6—Parkinson's disease	1.92e-06	1.09e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—IL6—Parkinson's disease	1.91e-06	1.08e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—IL6—Parkinson's disease	1.86e-06	1.05e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—IL6—Parkinson's disease	1.83e-06	1.03e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—INS—Parkinson's disease	1.76e-06	9.95e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—IL6—Parkinson's disease	1.68e-06	9.53e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—IL6—Parkinson's disease	1.66e-06	9.38e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—IL6—Parkinson's disease	1.65e-06	9.36e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—IL6—Parkinson's disease	1.65e-06	9.33e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—IL6—Parkinson's disease	1.64e-06	9.3e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—IL6—Parkinson's disease	1.63e-06	9.21e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—IL6—Parkinson's disease	1.62e-06	9.18e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IL6—Parkinson's disease	1.51e-06	8.53e-06	CbGpPWpGaD
